News

FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
FDA makes Juul’s reign official
JUUL GETS ITS CROWN — The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining ...
FDA Announces Major Recall of Popular Deodorant
It's important to stay informed about recalls, because doing so truly impacts your life. Of course, the sooner you know about ...
FDA Issues Risk Warning for Ice Cream Recalled in 23 States
Rich Ice Cream Co. recalled numerous lots of its products on June 27 over potential contamination with Listeria monocytogenes ...
National Law Review7h
FDA to Overhaul Post-Market Chemical Review Program for Food Chemicals
The U.S. Food and Drug Administration (FDA) announced plans to update its food safety post-market chemical review program ...
US FDA advisers recommend against Otsuka's PTSD combination treatment
The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...
CDC, FDA Warn of Possible Salmonella Risk From Frozen Sprouted Beans
Salmonella can cause diarrhea, fever, vomiting, stomach cramps, and dehydration. Most people recover within a week, but ...
Colorado Public Radio20h
Synthetic Psilocybin nears FDA review, signaling a potential shift in American mental healthcare
Supporters believe that FDA approval will make the drug more accessible. Right now, traditional psilocybin therapy offered at healing centers in the state is not covered by insurance.
Juul gets FDA’s OK to keep selling tobacco and menthol e-cigarettes
Federal health officials will allow Juul to keep selling its electronic cigarettes. The Food and Drug Administration said ...
Medscape18m
FDA Advisory Panel Votes NO on Belantamab for Myeloma
Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...